{
  "id": "c762f4bcc7114a27",
  "title": "Garetosmab Biologics License Application Accepted for FDA Priority Review for the Treatment of Fibrodysplasia Ossificans Progressiva ( FOP ) ",
  "description": "20260219T124500Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/02/19/tmt-newswire/globenewswire/garetosmab-biologics-license-application-accepted-for-fda-priority-review-for-the-treatment-of-fibrodysplasia-ossificans-progressiva-fop/2281025",
  "published_at": "20260219T124500Z",
  "fetched_at": "2026-02-20T00:27:32.210173+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/02/19/tmt-newswire/globenewswire/garetosmab-biologics-license-application-accepted-for-fda-priority-review-for-the-treatment-of-fibrodysplasia-ossificans-progressiva-fop/2281025",
    "url_mobile": "https://www.manilatimes.net/2026/02/19/tmt-newswire/globenewswire/garetosmab-biologics-license-application-accepted-for-fda-priority-review-for-the-treatment-of-fibrodysplasia-ossificans-progressiva-fop/2281025/amp",
    "title": "Garetosmab Biologics License Application Accepted for FDA Priority Review for the Treatment of Fibrodysplasia Ossificans Progressiva ( FOP ) ",
    "seendate": "20260219T124500Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/02/19/943462.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}